RxDoctor Payments DataLook up a doctor →

Sean Curzon, DO

Internal Medicine · Orem, UTNPI 1780600247

Payments from drug & device makers

$9,490in general payments, 2019–2025

Across 594 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$703
  • Pfizer$658
  • Boehringer Ingelheim$622
  • Mylan Specialty L.p.$530
  • GSK$500
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)107$1,827
Amgen(2 entities)39$703
Pfizer54$658
Boehringer Ingelheim33$622
Mylan Specialty L.p.35$530
GSK32$500
Lilly USA, LLC42$484
AstraZeneca29$476
Astellas Pharma US Inc21$362
Novo Nordisk16$264
Bayer15$249
Johnson & Johnson18$180
Otsuka America Pharmaceutical, Inc.10$164
Boston Scientific8$151
Sanofi-aventis U.S. LLC9$148
Sunovion Pharmaceuticals Inc.13$147
Sumitomo Pharma America, Inc.10$126
Merck7$110
Lundbeck LLC5$105
Abbott5$95
Sanofi Pasteur Inc.3$87
Arbor Pharmaceuticals, Inc.6$79
Novartis5$77
Kowa Pharmaceuticals America, Inc.1$65
Xeris Pharmaceuticals, Inc.3$63
Biohaven Pharmaceutical Holding Company Ltd.3$63
Axsome Therapeutics, Inc.3$61
Teva Pharmaceuticals USA, Inc.4$59
Exact Sciences3$49
Dexcom, Inc.3$49
Supernus Pharmaceuticals, Inc.3$48
Aimmune Therapeutics, Inc.2$46
Phathom Pharmaceuticals, Inc.3$43
Azurity Pharmaceuticals, Inc.3$43
Biohaven Pharmaceuticals, Inc.3$43
E.r. Squibb & Sons, L.L.C.2$43
Edwards Lifesciences2$42
Nestle Healthcare Nutrition Inc.2$41
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Ironwood Pharmaceuticals, Inc3$37
Irhythm Technologies, Inc.1$36
Nevro Corp.1$32
Harmony Biosciences LLC2$30
Viatris Specialty LLC1$29
Averitas Pharma Inc.1$28
Amarin Pharma, Inc.2$28
Medtronic(2 entities)2$27
Madrigal Pharmaceuticals1$26
Actelion Pharmaceuticals US, Inc.1$25
Therapeuticsmd, Inc.1$23
Verity Pharmaceuticals Inc.1$22
GE HealthCare1$22
Endo Pharmaceuticals Inc.1$19
Inspire Medical Systems, Inc.1$19
Idorsia Pharmaceuticals US Inc1$18
Lucid Diagnostics Inc.1$17
Almatica Pharma LLC1$16
MDD US Operations, LLC1$14
Antares Pharma, Inc.1$14
Ferring Pharmaceuticals Inc.1$14

How this compares

$9,490 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$250,856
Medicare patients
427
Services billed
7,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Orem

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →